30/11/2017 | News & Events / Events
We are glad to announce that our CEO, Roberto Ascione, will be member of the Jury of the first edition of the Life Science and Health Investor Lunch Helsinki on 30 November 2017.
The event - organized by Tech Tour, Health Capital Helsinki, Finpro and Tekes in collaboration with Slush - aims to bring together highly promising preselected life science and health startups with international investors focusing on biotech, pharma, diagnostics, personalized medicine, remote monitoring and diagnosis, as well as other life science sectors.
The startups will have the opportunity to pitch and only 5 out of 20 will be selected to present in front of relevant key industry players.
Follow us on Twitter to get live updates.